Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | AMGN | GILD | CELG | VRTX |
| Company | Catabasis Pharma | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 9.21 | 312.89 | 64.72 | 108.01 | 420.67 |
| High | 9.21 | 314.89 | 66.20 | 108.59 | 423.32 |
| Low | 8.46 | 309.82 | 64.67 | 107.27 | 417.50 |
| Last | 8.54 | 310.15 | 65.96 | 108.24 | 422.78 |
| Change | -0.64 | -2.71 | +1.38 | +0.11 | +3.79 |
| % Change | -6.97% | -0.87% | +2.14% | +0.10% | +0.90% |
| Volume | 98,800 | 2,611,745 | 8,732,673 | 191,230,496 | 1,064,481 |
| 20-Day Average Volume | 395,311 | 2,930,857 | 7,614,349 | 16,188,930 | 1,107,774 |
| Previous Close | 9.18 | 312.86 | 64.58 | 108.13 | 418.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 281.61 | 65.99 | 108.17 | 401.94 |
| 20-Day Raw Stochastic | 56.46% | 79.89% | 39.52% | 63.25% | 91.71% |
| 20-Day Relative Strength | 43.24% | 65.95% | 39.82% | 64.69% | 62.31% |
| Weighted Alpha | -50.43 | +34.03 | -19.29 | +46.30 | +22.92 |
| Today's Opinion | 88% Sell | 56% Buy | 100% Sell | 100% Buy | 56% Buy |
| Previous Opinion | 72% Sell | 56% Buy | 100% Sell | 100% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | -0.37% since 05/03/24 | +1.82% since 05/03/24 | -1.97% since 11/13/19 | +5.41% since 05/03/24 |
| Low | 8.46 on 09/08/21 | 297.52 on 05/06/24 | 64.34 on 05/06/24 | 107.27 on 11/20/19 | 394.03 on 05/07/24 |
| High | 10.26 on 09/02/21 | 314.89 on 05/10/24 | 66.20 on 05/10/24 | 110.53 on 11/14/19 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | +16.40% since 04/10/24 | -3.17% since 04/10/24 | +5.14% since 10/18/19 | +6.34% since 04/10/24 |
| Low | 6.31 on 08/20/21 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 10.26 on 09/02/21 | 322.60 on 05/03/24 | 69.03 on 04/11/24 | 110.70 on 11/13/19 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | +6.54% since 02/09/24 | -10.47% since 02/09/24 | +13.63% since 08/20/19 | -0.03% since 02/09/24 |
| Low | 6.31 on 08/20/21 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 15.72 on 06/16/21 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | +16.03% since 11/10/23 | -13.12% since 11/10/23 | +14.14% since 05/20/19 | +13.15% since 11/10/23 |
| Low | 6.31 on 08/20/21 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 22.01 on 03/18/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 167,829,040 | 80,407,072 | 77,035,920 | 108,121,632 |
| Shares Outstanding, K | 3,904 | 536,435 | 1,245,077 | 711,714 | 258,053 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -37,300,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -7,470,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.66 | 0.60 | 0.22 | 1.41 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.76 on 05/06/24 |
| Latest Earnings Date | 08/09/21 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 16.11 | 10.99 | 27.81 |